Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

di Morice, Pierre-Marie, Coquan, Elodie, Weiswald, Louis-Bastien, Lambert, Bernard, Vaur, Dominique, Poulain, Laurent
Pubblicato in Br J Cancer (2021)

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study

di Johnson, Alison C., Matias, Margarida, Boyle, Helen, Escudier, Bernard, Molinier, Alicia, Laguerre, Brigitte, Helissey, Carole, Brachet, Pierre-Emmanuel, Dugué, Audrey Emmanuelle, Mourey, Loic, Coquan, Elodie, Joly, Florence
Pubblicato in BMC Cancer (2017)

Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in sta...

di Aide, Nicolas, Fauchille, Pauline, Coquan, Elodie, Ferron, Gwenael, Combe, Pierre, Meunier, Jérome, Alexandre, Jerôme, Berton, Dominique, Leary, Alexandra, De Rauglaudre, Gaétan, Bonichon, Nathalie, Pujade Lauraine, Eric, Joly, Florence
Pubblicato in Eur J Nucl Med Mol Imaging (2020)

Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol

di Lange, Marie, Laviec, Heidi, Castel, Hélène, Heutte, Natacha, Leconte, Alexandra, Léger, Isabelle, Giffard, Bénédicte, Capel, Aurélie, Dubois, Martine, Clarisse, Bénédicte, Coquan, Elodie, Di Fiore, Frédéric, Gouérant, Sophie, Bartélémy, Philippe, Pierard, Laure, Fizazi, Karim, Joly, Florence
Pubblicato in BMC Cancer (2017)

Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol

di Lange, Marie, Laviec, Heidi, Castel, Hélène, Heutte, Natacha, Leconte, Alexandra, Léger, Isabelle, Giffard, Bénédicte, Capel, Aurélie, Dubois, Martine, Clarisse, Bénédicte, Coquan, Elodie, Di Fiore, Frédéric, Gouérant, Sophie, Bartélémy, Philippe, Pierard, Laure, Fizazi, Karim, Joly, Florence
Pubblicato in BMC Cancer (2018)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

di Lesueur, Paul, Lequesne, Justine, Grellard, Jean-Michel, Dugué, Audrey, Coquan, Elodie, Brachet, Pierre-Emmanuel, Geffrelot, Julien, Kao, William, Emery, Evelyne, Berro, David Hassanein, Castera, Laurent, Goardon, Nicolas, Lacroix, Joëlle, Lange, Marie, Capel, Aurélie, Leconte, Alexandra, Andre, Benoit, Léger, Angélique, Lelaidier, Anaïs, Clarisse, Bénédicte, Stefan, Dinu
Pubblicato in BMC Cancer (2019)